Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Calvin Yeang

Showing results (31-40 of 50) with videos related to

Pageof 5
Sort By:
International Journal of Cardiology|May 11, 2020
Short-term regulation of hematopoiesis by lipoprotein(a) results in the production of pro-inflammatory monocytesJohan G Schnitzler, Kikkie Poels, Lotte C A Stiekema, et al.
Atherosclerosis|August 22, 2023
Lipoprotein(a) and the pooled cohort equations for ASCVD risk prediction: The Multi-Ethnic Study of AtherosclerosisHarpreet S Bhatia, Rishi Rikhi, Tara S Allen, et al.
Circulation Research|April 29, 2016
PCSK9 Association With Lipoprotein(a)Hagai Tavori, Devon Christian, Jessica Minnier, et al.
JACC. Basic to Translational Science|November 18, 2017
Lipoprotein(a) Associated Molecules are Prominent Components in Plasma and Valve Leaflets in Calcific Aortic Valve StenosisMichael Torzewski, Amir Ravandi, Calvin Yeang, et al.
The Lancet. Diabetes & Endocrinology|July 24, 2023
Lipoprotein(a) and carotid intima-media thickness in children with familial hypercholesterolaemia in the Netherlands: a 20-year follow-up studyLotte M de Boer, Albert Wiegman, Jeffrey Kroon, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|October 14, 2021
Lipoprotein(a): A Genetically Determined, Causal, and Prevalent Risk Factor for Atherosclerotic Cardiovascular Disease: A Scientific Statement From the American Heart AssociationGissette Reyes-Soffer, Henry N Ginsberg, Lars Berglund, et al.
JAMA Cardiology|June 4, 2025
AHA PREVENT Equations and Lipoprotein(a) for Cardiovascular Disease Risk : Insights From MESA and the UK BiobankHarpreet S Bhatia, Matthew Ambrosio, Alexander C Razavi, et al.
Atherosclerosis|February 11, 2022
Trends in testing and prevalence of elevated Lp(a) among patients with aortic valve stenosisHarpreet S Bhatia, Gary S Ma, Adam Taleb, et al.
Journal of the American College of Cardiology|September 12, 2015
Oxidized Phospholipids, Lipoprotein(a), and Progression of Calcific Aortic Valve StenosisRomain Capoulade, Kwan L Chan, Calvin Yeang, et al.
Atherosclerosis|May 3, 2025
Interleukin-6 modifies Lipoprotein(a) and oxidized phospholipids associated cardiovascular disease risk in a secondary prevention cohortNiekbachsh Mohammadnia, Amber van Broekhoven, Willem A Bax, et al.
Pageof 5

Showing results (31-40 of 50) with videos related to

Sort By:
Pageof 5
International Journal of Cardiology|May 11, 2020
Short-term regulation of hematopoiesis by lipoprotein(a) results in the production of pro-inflammatory monocytesJohan G Schnitzler, Kikkie Poels, Lotte C A Stiekema, et al.
Atherosclerosis|August 22, 2023
Lipoprotein(a) and the pooled cohort equations for ASCVD risk prediction: The Multi-Ethnic Study of AtherosclerosisHarpreet S Bhatia, Rishi Rikhi, Tara S Allen, et al.
Circulation Research|April 29, 2016
PCSK9 Association With Lipoprotein(a)Hagai Tavori, Devon Christian, Jessica Minnier, et al.
JACC. Basic to Translational Science|November 18, 2017
Lipoprotein(a) Associated Molecules are Prominent Components in Plasma and Valve Leaflets in Calcific Aortic Valve StenosisMichael Torzewski, Amir Ravandi, Calvin Yeang, et al.
The Lancet. Diabetes & Endocrinology|July 24, 2023
Lipoprotein(a) and carotid intima-media thickness in children with familial hypercholesterolaemia in the Netherlands: a 20-year follow-up studyLotte M de Boer, Albert Wiegman, Jeffrey Kroon, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|October 14, 2021
Lipoprotein(a): A Genetically Determined, Causal, and Prevalent Risk Factor for Atherosclerotic Cardiovascular Disease: A Scientific Statement From the American Heart AssociationGissette Reyes-Soffer, Henry N Ginsberg, Lars Berglund, et al.
JAMA Cardiology|June 4, 2025
AHA PREVENT Equations and Lipoprotein(a) for Cardiovascular Disease Risk : Insights From MESA and the UK BiobankHarpreet S Bhatia, Matthew Ambrosio, Alexander C Razavi, et al.
Atherosclerosis|February 11, 2022
Trends in testing and prevalence of elevated Lp(a) among patients with aortic valve stenosisHarpreet S Bhatia, Gary S Ma, Adam Taleb, et al.
Journal of the American College of Cardiology|September 12, 2015
Oxidized Phospholipids, Lipoprotein(a), and Progression of Calcific Aortic Valve StenosisRomain Capoulade, Kwan L Chan, Calvin Yeang, et al.
Atherosclerosis|May 3, 2025
Interleukin-6 modifies Lipoprotein(a) and oxidized phospholipids associated cardiovascular disease risk in a secondary prevention cohortNiekbachsh Mohammadnia, Amber van Broekhoven, Willem A Bax, et al.
Pageof 5